First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors

NEXT STORY
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
PREV STORY
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346

author_avatar
NASDAQ Market News

NOVEL NANOBODY TO START CLINICAL DEVELOPMENT IN OSTEOARTHRITIS – ABLYNX TO RECEIVE €15 MILLION MILESTONE PAYMENT

GHENT, Belgium, 22 May 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations

author_avatar
NASDAQ Market News